| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_680dd0699e3f4ba8532d128c7152b3bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88e451f94d9018c7dabfa165537b805c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-805 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-805 |
| filingDate |
1998-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7810a9ec4c24905c4c9c8f08c4dcc0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47104697f4643fdc3d8124fba9d9b047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0db254ec8587f53b5ac5370691709c5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6235e94d2ab57b22a93295ca07793395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e6e2b48998408ed8949a12825bcea1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d64659fda253bc0414298f8ef691b6c6 |
| publicationDate |
2000-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0979279-A2 |
| titleOfInvention |
Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| abstract |
The invention relates to novel recombinant hemoglobins having reduced nitric oxide scavenging and/or increased high soluble expression. The invention further relates to methods of increasing the soluble expression of recombinant hemoglobin by adding exogenous hemin in molar excess of the heme binding sites of recombinant hemoglobin. |
| priorityDate |
1997-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |